Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A research team from the UCLA Health Jonsson Comprehensive Cancer Center, the University of Texas MD Anderson Cancer Center, and collaborators have demonstrated that a novel topical BRAF inhibitor gel ...

Still itching after topical steroids? Here's why your atopic dermatitis symptoms may still be flaring and what you can do about it.

Please provide your email address to receive an email when new articles are posted on . Phase 2a interim data show 100% of patients achieving the primary endpoint of skin toxicity improvement. Also, ...

New research reveals how calcipotriol-plus–5-FU therapy activates immune pathways to prevent squamous cell carcinoma with long-lasting protection. Study: T helper 2 cell–directed immunotherapy ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Melanomas make up a slightly smaller number of skin cancer cases than BCC or SCC, but malignant melanoma is much more aggressive and tends to spread to other parts of the body. These cancers may be ...